Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy
Background Circulating tumour DNA from colorectal cancer (CRC) is a biomarker for early detection of the disease and therefore potentially useful for screening. One such biomarker is the methylated SEPT9 (mSEPT9) gene, which occurs during CRC tumourigenesis. This systematic review and meta-analysis...
Saved in:
| Main Authors: | Rohit Hariharan, Mark Jenkins |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2020-12-01
|
| Series: | BMJ Open Gastroenterology |
| Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000355.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of SDC2 and SEPT9 methylation tests in the early detection of colorectal cancer: a systematic review and meta-analysis
by: Jie Zhang, et al.
Published: (2024-12-01) -
Diagnostic accuracy of methylated SEPT9 for primary liver cancer: a systematic review and meta-analysis
by: Danwen Jin, et al.
Published: (2025-02-01) -
Methylation of SEPT9 and LINC00473 Genes in Circulating Cell-Free DNA as a Potential Biomarker for the Early Detection of Colorectal Polyps
by: Masoud Tat, et al.
Published: (2025-06-01) -
Analysis of SDC2 and SEPT9 promoters methylation in plasma cfDNA to detect colorectal and precancerous lesions
by: Viktoria Borobova, et al.
Published: (2025-05-01) -
Liquid biopsy of colorectal cancer: a new approach to evaluation of aberrant methylation of the <i>SEPT9</i> gene
by: I. V. Botezatu, et al.
Published: (2021-12-01)